BR112013022504A2 - sal de gentisato, de adipato, de ácido trifluoroacético, forma cristalina de hidrocloreto, forma cristalina de besilato, besilato amórfico e processos para a preparação dos mesmos - Google Patents
sal de gentisato, de adipato, de ácido trifluoroacético, forma cristalina de hidrocloreto, forma cristalina de besilato, besilato amórfico e processos para a preparação dos mesmosInfo
- Publication number
- BR112013022504A2 BR112013022504A2 BR112013022504A BR112013022504A BR112013022504A2 BR 112013022504 A2 BR112013022504 A2 BR 112013022504A2 BR 112013022504 A BR112013022504 A BR 112013022504A BR 112013022504 A BR112013022504 A BR 112013022504A BR 112013022504 A2 BR112013022504 A2 BR 112013022504A2
- Authority
- BR
- Brazil
- Prior art keywords
- crystalline form
- besylate
- gentisate
- adipate
- hydrochloride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN590MU2011 | 2011-03-03 | ||
| IN1948MU2011 | 2011-07-06 | ||
| IN2777MU2011 | 2011-09-30 | ||
| PCT/IN2012/000148 WO2012147092A2 (en) | 2011-03-03 | 2012-03-02 | Novel salts of dpp-iv inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013022504A2 true BR112013022504A2 (pt) | 2016-07-19 |
| BR112013022504A8 BR112013022504A8 (pt) | 2018-01-23 |
Family
ID=54290089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013022504A BR112013022504A8 (pt) | 2011-03-03 | 2012-03-02 | sal de gentisato, de adipato, de ácido trifluoroacético, forma cristalina de hidrocloreto, forma cristalina de besilato, besilato amórfico e processos para a preparação dos mesmos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9108972B2 (pt) |
| EP (4) | EP2899194A1 (pt) |
| JP (1) | JP2014510071A (pt) |
| KR (1) | KR20130132631A (pt) |
| CN (2) | CN103476778A (pt) |
| AU (1) | AU2012247127B2 (pt) |
| BR (1) | BR112013022504A8 (pt) |
| DK (1) | DK2681220T3 (pt) |
| ES (1) | ES2548269T3 (pt) |
| MX (1) | MX2013010027A (pt) |
| PH (1) | PH12015501536A1 (pt) |
| SG (2) | SG10201405403QA (pt) |
| WO (1) | WO2012147092A2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140350023A1 (en) * | 2011-12-08 | 2014-11-27 | Ranbaxy Laboratories Limited | Amorphous form of sitagliptin salts |
| MX2016016260A (es) * | 2016-12-08 | 2018-06-07 | Alparis Sa De Cv | Nuevas formas solidas de sitagliptina. |
| GR1010089B (el) | 2020-09-15 | 2021-09-27 | Φαρματεν Α.Β.Ε.Ε. | Στερεη φαρμακοτεχνικη μορφη περιεχουσα σιταγλιπτινη και μεθοδος παρασκευης αυτης |
| GR1010234B (el) | 2021-04-27 | 2022-05-18 | Φαρματεν Α.Β.Ε.Ε., | Φαρμακευτικο σκευασμα που περιλαμβανει συνδυασμο σιταγλιπτινης και μετφορμινης και μεθοδος για την παρασκευη αυτου |
| WO2023139276A1 (en) | 2022-01-24 | 2023-07-27 | Zaklady Farmaceutyczne Polpharma S.A. | Process for preparing crystalline sitagliptin hydrochloride monohydrate |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3174901A (en) * | 1963-01-31 | 1965-03-23 | Jan Marcel Didier Aron Samuel | Process for the oral treatment of diabetes |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| JO2625B1 (en) | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
| CN100457108C (zh) | 2003-09-02 | 2009-02-04 | 默克公司 | 一种二肽基肽酶iv抑制剂的磷酸盐新晶体 |
| US20070021430A1 (en) | 2003-09-23 | 2007-01-25 | Chen Alex M | Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| US20080227786A1 (en) | 2004-01-16 | 2008-09-18 | Ferlita Russell R | Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor |
| US7612072B2 (en) | 2004-09-15 | 2009-11-03 | Merck & Co., Inc. | Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| ATE540950T1 (de) * | 2005-05-25 | 2012-01-15 | Merck Sharp & Dohme | Aminocyclohexane als dipeptidylpeptidase-iv- hemmer zur behandlung bzw. prävention von diabetes |
| WO2007035198A2 (en) | 2005-07-25 | 2007-03-29 | Merck & Co., Inc. | Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
| CA2625646A1 (en) * | 2005-10-25 | 2007-05-03 | Merck & Co., Inc. | Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| SI2032521T1 (sl) | 2006-06-27 | 2010-02-26 | Sandoz Ag | Nov postopek za pripravo soli |
| JP5460324B2 (ja) * | 2006-10-12 | 2014-04-02 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 治療剤としてのスピロ−オキシインドール化合物の使用 |
| MX2009003874A (es) * | 2006-10-12 | 2009-04-22 | Xenon Pharmaceuticals Inc | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. |
| EP2019113A1 (en) | 2007-07-26 | 2009-01-28 | Anadys Pharmaceuticals, Inc. | New Crystalline Salts of 5-Amino-3-(2',3'-di-O-acetyl-beta-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one |
| EP2190819B1 (en) * | 2007-08-09 | 2016-05-25 | Rensselaer Polytechnic Institute | Quaternary opioid carboxamides |
| CN101903390A (zh) * | 2007-12-20 | 2010-12-01 | 雷迪博士实验室有限公司 | 制备西他列汀及其药学上可接受的盐的方法 |
| EP2650297A1 (en) | 2008-07-03 | 2013-10-16 | Ratiopharm GmbH | Crystalline salts of sitagliptin |
| FR2933692B1 (fr) | 2008-07-10 | 2022-12-02 | Univ Nancy 1 Henri Poincare | Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation |
| EP2324027B1 (en) | 2008-07-29 | 2016-02-24 | Medichem, S.A. | New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative |
| US8476437B2 (en) | 2008-08-27 | 2013-07-02 | Cadila Healthcare Limited | Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof |
| US8278486B2 (en) * | 2008-12-31 | 2012-10-02 | Chiral Quest, Inc. | Process and intermediates for the preparation of N-acylated-4-aryl beta-amino acid derivatives |
| EP2218721A1 (en) | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
| KR20110135397A (ko) | 2009-03-30 | 2011-12-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 시타글립틴 염의 고체 상태 형태 |
| EP2407469A1 (en) | 2010-07-13 | 2012-01-18 | Chemo Ibérica, S.A. | Salt of sitagliptin |
| CA2840806A1 (en) | 2011-06-30 | 2013-01-03 | Ranbaxy Laboratories Limited | Novel salts of sitagliptin |
-
2012
- 2012-03-02 US US14/002,541 patent/US9108972B2/en not_active Expired - Fee Related
- 2012-03-02 KR KR1020137026089A patent/KR20130132631A/ko not_active Application Discontinuation
- 2012-03-02 EP EP14196602.8A patent/EP2899194A1/en not_active Withdrawn
- 2012-03-02 ES ES12766329.2T patent/ES2548269T3/es active Active
- 2012-03-02 SG SG10201405403QA patent/SG10201405403QA/en unknown
- 2012-03-02 EP EP14171186.1A patent/EP2789616A1/en not_active Withdrawn
- 2012-03-02 EP EP20140196352 patent/EP2860180A1/en not_active Withdrawn
- 2012-03-02 DK DK12766329.2T patent/DK2681220T3/en active
- 2012-03-02 MX MX2013010027A patent/MX2013010027A/es not_active Application Discontinuation
- 2012-03-02 WO PCT/IN2012/000148 patent/WO2012147092A2/en active Application Filing
- 2012-03-02 CN CN2012800168764A patent/CN103476778A/zh active Pending
- 2012-03-02 JP JP2013555995A patent/JP2014510071A/ja active Pending
- 2012-03-02 BR BR112013022504A patent/BR112013022504A8/pt not_active IP Right Cessation
- 2012-03-02 AU AU2012247127A patent/AU2012247127B2/en not_active Expired - Fee Related
- 2012-03-02 EP EP12766329.2A patent/EP2681220B1/en not_active Not-in-force
- 2012-03-02 CN CN201510112504.7A patent/CN104788456A/zh active Pending
- 2012-03-02 SG SG2013064886A patent/SG192973A1/en unknown
-
2015
- 2015-07-08 PH PH12015501536A patent/PH12015501536A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130132631A (ko) | 2013-12-04 |
| SG10201405403QA (en) | 2014-11-27 |
| CN104788456A (zh) | 2015-07-22 |
| WO2012147092A3 (en) | 2013-03-14 |
| US9108972B2 (en) | 2015-08-18 |
| JP2014510071A (ja) | 2014-04-24 |
| SG192973A1 (en) | 2013-09-30 |
| US20140051856A1 (en) | 2014-02-20 |
| EP2860180A1 (en) | 2015-04-15 |
| AU2012247127B2 (en) | 2016-01-28 |
| PH12015501536A1 (en) | 2015-09-21 |
| EP2681220B1 (en) | 2015-08-19 |
| BR112013022504A8 (pt) | 2018-01-23 |
| ES2548269T3 (es) | 2015-10-15 |
| CN103476778A (zh) | 2013-12-25 |
| DK2681220T3 (en) | 2015-11-30 |
| WO2012147092A2 (en) | 2012-11-01 |
| EP2681220A2 (en) | 2014-01-08 |
| AU2012247127A1 (en) | 2013-10-03 |
| EP2899194A1 (en) | 2015-07-29 |
| EP2789616A1 (en) | 2014-10-15 |
| MX2013010027A (es) | 2014-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2022031I1 (no) | Voxelotor or a tautomer or pharmaceutically acceptable salt thereof | |
| BR112013027637A2 (pt) | processo para a preparação de um sal de metal trialcalino de l-mgda cristalino por cristalização, e, sal de metal trialcalino de l-mgda cristalino | |
| ZA201405503B (en) | Novel nicotinamide derivative or salt thereof | |
| CO6821956A2 (es) | Proceso para preparar fumarato de dimetilo de alta pureza y cristalino | |
| HK1195770A1 (en) | Amorphous solid salts of cobicistat (gs-9350) (cobicistat)(gs-9350) | |
| EP2563790A4 (en) | PROCESS FOR A QUATERNARY AMMONIA SALT | |
| BR112012029226A2 (pt) | processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto | |
| PL2785701T3 (pl) | Krystaliczna postać kabazytakselu i sposób jej otrzymywania | |
| ZA201308160B (en) | Crystalline salts of asenapine | |
| IL228810A0 (en) | A crystalline form of a salt of a morpholinosulfonyl indole derivative and a process for its preparation | |
| FI20116334A (fi) | Eukaryottiset solut ja menetelmä glykolihapon valmistamiseksi | |
| BR112013022504A2 (pt) | sal de gentisato, de adipato, de ácido trifluoroacético, forma cristalina de hidrocloreto, forma cristalina de besilato, besilato amórfico e processos para a preparação dos mesmos | |
| PL2448945T3 (pl) | Krystaliczne postacie soli prasugrelu | |
| BR112014001571A2 (pt) | processo para preparar derivados de ácido carboxílico | |
| PT2571355T (pt) | Sal de cloridrato cristalino de darunavir | |
| BR112013017831A2 (pt) | método para a preparação de ácido nicotínico | |
| FR2993556B1 (fr) | Procede de preparation d'un compose sulfonimide et de ses sels | |
| ZA201204108B (en) | Crystalline forms of bosentan salts and processes for their preparation | |
| HK1200454A1 (zh) | 琥珀酸鹽的晶形 | |
| ZA201404666B (en) | Process for preparing and purifying salts of acrylamido-2-methylpropanesulfonic acid | |
| EP2751074A4 (en) | 5-SULPHISOPHTHALIC ACID SALTS AND PROCESS FOR THE PREPARATION THEREOF | |
| EP2698371A4 (en) | NEW VERBUNDADDITIONSALZ AGAINST THROMBOCYTES | |
| BR112012024247A2 (pt) | polimorfos cristalinos, sal ácido e composição farmacêutica | |
| IL218764A0 (en) | Crystalline levofolinic acid and process for its preparation | |
| CO6811871A2 (es) | Proceso para la cristalización de un compuesto soluble en agua |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |